Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-01
2005-03-01
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S594000
Reexamination Certificate
active
06861420
ABSTRACT:
The present invention provides compounds of Formula I:wherein X, R1, R2, R3, R4, R5, and R6have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula I.
REFERENCES:
patent: 5132311 (1992-07-01), Liang
patent: 20020019389 (2002-02-01), Kim et al.
patent: WO 9748699 (1997-12-01), None
patent: WO 9748700 (1997-12-01), None
patent: WO 0195856 (2001-12-01), None
Robichaud et al. (Annual reports in Medicinal Chemistry 35, Chapter 2) 2000.
Flynn ,Thiel, Boutell & Tanis, P.C.
Kifle Bruck
Pharmacia & Upjohn Company
LandOfFree
N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373040